Clinical Trials Directory

Trials / Completed

CompletedNCT00827944

Parietex Progrip Study

ProGrip Mesh Repair Versus Lichtenstein Mesh Repair: a Comparative Randomized Study in Primary Inguinal Hernia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
603 (actual)
Sponsor
Medtronic - MITG · Industry
Sex
Male
Age
31 Years – 74 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to evaluate pain and disabling complications inducing social consequences in primary inguinal hernia ProGrip mesh repair compared to Lichtenstein repair with lightweight polypropylene mesh.

Detailed description

* Patients in ProGrip group will be treated with self-gripping lightweight Polyester and Polylactic acid meshes providing a sutureless fixation. * Patients in Lichtenstein group will be treated with lightweight Polypropylene meshes requiring fixation by sutures. * Study participation will start at signature of informed consent and each patient will be assessed before surgery. A close follow-up will be performed: 7 days (questionnaires and phone call), 1 month (clinical visit), 3 months (questionnaires and phone call), and final evaluation at 12 months (clinical visit) after surgery, which will end the participation to the study. * 600 adult males divided in 2 groups requiring primary uncomplicated elective inguinal hernia mesh repair will be included in the study. Patients will be stratified by center.

Conditions

Interventions

TypeNameDescription
DEVICEParietex ProgripSurgical technique: Self-gripping lightweight Polyester and Polylactic acid meshes providing a sutureless fixation.
DEVICELow weight polypropylene meshSurgical technique: Lichtenstein repair with lightweight polypropylene mesh (inferior to 70gr/m2) secured to the posterior inguinal wall with sutures

Timeline

Start date
2008-10-01
Primary completion
2012-10-01
Completion
2012-10-01
First posted
2009-01-23
Last updated
2016-11-17
Results posted
2016-11-17

Locations

9 sites across 5 countries: Belgium, Germany, Netherlands, Sweden, United Kingdom

Source: ClinicalTrials.gov record NCT00827944. Inclusion in this directory is not an endorsement.